Skip to main content

Table 2 Baseline characteristics of the target patient population

From: Increasing system-wide implementation of opioid prescribing guidelines in primary care: findings from a non-randomized stepped-wedge quality improvement project

Characteristics Intervention clinics at baseline
(N = 1431)
Comparison clinics at baseline
(N = 1717)
p value*
Women, % (SD) 57.7 (7.1) 60.7 (8.9) 0.400
Mean age, years, mean (SD) 53.6 (3.2) 53.8 (3.5) 0.864
Completed treatment agreement (past 12 months), % (SD) 24.8 (13.8) 29.2 (18.3) 0.531
Completed urine drug testing (past 12 months), % (SD) 24.7 (11.8) 31.3 (16.2) 0.285
Completed depression screening (past 12 months), % (SD) 8.1 (10.4) 1.1 (1.3) 0.019
Completed opioid misuse risk assessment, % (SD) 0.2 (0.4) 0.7 (1.8) 0.478
Documented PDMP Check (past 12 months), % (SD) 0.0 (0.1) 0.3 (1.2) 0.503
Co-prescribed benzodiazepines in at least 1 out of 3 past months, % (SD) 19.9 (4.3) 24.7 (7.4) 0.089
Percentage of the adult clinic population, % (SD) 2.0 (0.9) 2.1 (0.6) 0.906
MED (past 90 days), mg/day, mean (SD) 75.7 (29.7) 55.9 (19.4) 0.063
MED ≥ 90 mg/day (past 90 days), % (SD) 23.0 (8.8) 15.5 (7.3) 0.038
  1. Population of adult patients with opioid-treated chronic non-cancer pain in the 9 intervention and 17 comparison primary care clinics: characteristics at baseline (January 2016) based on the equally-weighted clinic averages
  2. MED Morphine-equivalent Dose, PDMP Prescription Drug Monitoring Program, SD standard deviation
  3. * p value was determined using the two-sample means test comparing clinic-level values for intervention versus comparison clinic groups